Buyer's guide / At-home micro-infusion

Seranova vs Qure vs Glov vs EvenSkyn: At-Home Micro-Infusion Kits Compared

Nine brands, one shared depth ceiling, and a set of differences that sit in the hygiene design rather than the marketing.

By the EvenSkyn Skin Science Desk · Published 27 May 2026 · Last reviewed 13 August 2026

What an at-home micro-infusion kit actually does

An at-home micro-infusion kit is a hand-held stamp fitted with a small array of fine needles and a reservoir of serum. Pressing it against the skin opens temporary micro-channels through the outer layer, and serum travels down those channels instead of sitting on the surface. The mechanical injury is deliberate and small: it is meant to prompt the skin's ordinary repair response while giving actives a shorter route in. Nothing is injected under pressure, which is the most common misunderstanding about the category.

That description covers every kit here. The differences between brands are not in the physics. They are in how the serum reaches the needles, whether anything is reused between sessions, what is dissolved in the serum, and how honestly the packaging describes what half a millimetre can do.

The Depth Ceiling Test

Before comparing brands, it helps to know where these devices sit on the depth scale, because depth is what separates a home cosmetic device from a clinic procedure. We use a simple screen we call the Depth Ceiling Test: find the device's fixed depth, then ask whether the outcome you want has ever been demonstrated at that depth. If the answer is no, the device is not the wrong purchase, but the expectation is the wrong expectation.

The honest consequence: a 0.5 mm home device and a 2 mm clinic pen are not the same treatment at different price points. They are different treatments. Anyone marketing a home kit as equivalent to a clinic system is overselling, and that includes any brand named on this page.

The category's real question is not which kit goes deepest. They all stop in the same place. It is which kit gets a sterile needle and a fresh serum to that place without contaminating either.

The four criteria that decide this purchase

These are the criteria we compared all nine brands on, ranked by how much they change the outcome or the risk. Price is deliberately absent: at this depth, the difference between a well-designed kit and a poorly designed one is a hygiene and formulation difference, not a spending difference.

1. Is anything reused between sessions?

   This is the criterion with the clearest safety literature behind it. The FDA's guidance on microneedling devices instructs users not to reuse a needle cartridge, warning that reuse could transfer infectious agents, and a 2024 review in Cosmetics notes that reusing needle cartridges can cause or spread infection. A kit that pairs one sterile head with one sealed serum dose per session removes that pathway by design. A kit with a refillable chamber does not.

2. How does the serum reach the needles?

   Pouring serum into an open chamber exposes it to fingers, air and whatever was in the chamber last time. A sealed path from ampoule to needle head keeps that contact from happening. This matters more than it sounds, because the channels you are about to open are the shortest route bacteria will ever have into your dermis.

3. What is actually dissolved in the serum, and where did it come from?

   Most PDRN on the market is extracted from fish. A 2022 review describes PDRN as consisting of DNA fragments mainly extracted from the sperm cells of salmon trout or chum salmon. Fermentation-derived PDRN is made in a bioreactor instead. Both are PDRN. The sourcing question is about what else arrives with it and whether the brand will tell you.

4. Does the documentation tell you when not to use it?

   A manual that lists isotretinoin, anticoagulants, keloid history, active infection and pregnancy as reasons to stop is a manual written by someone who expected the device to be used by adults with medical histories. A manual that only lists benefits is a marketing document.

How the nine systems compare

Every figure below was read on 28 July 2026 from the manufacturer's own published material: our own manual and product page for the MicroInfuser, and each brand's own website for the others. Where a brand publishes different numbers in different places, we have printed both rather than picking the one that suits us.

What we added, and the names we deliberately left out

This comparison started at four systems, went to seven, and now covers nine. Elixa, Alqemi and Glamory earned columns in August. Rewind Glow and the Dr. Pen MIS20 kit earned columns on 13 August 2026, and we added two new rows at the same time: whether the brand names a sterilisation method, and whether you can identify the company behind the product. We keep this list here rather than quietly updating the table, because a comparison that changes without saying so is not a comparison you can check.

Rewind Glow is in the table as the transparency floor. It is a genuine open-fill micro-infusion system, and it publishes no needle count, no needle depth, no serum name, no serum volume and no sterilisation information. Its own material avoids the word needle, calling them touchpoints. Its one-month kit ships two applicators against six serums while the FAQ says each head is single use, and those two statements do not reconcile.

Dr. Pen MIS20 needs a caveat that belongs in the open. Dr. Pen is known for motorised microneedling pens, and drpen.com sells pens, not this. The MIS20 stamp kit is sold by the brand's Australian distributor, eShopping Group Pty Ltd, and it is the only product in this table whose seller publishes a company registration number. It is stated at 0.25 mm rather than 0.5 mm, which made it the shallowest kit here until Glov's own published figure moved to 0.25 mm (31 August 2026).

Five other names come up constantly in searches for this category and none of them belong in the table. We are naming them because a shopper comparing them side by side with the nine above is comparing two different tools.

• Oros sells a dissolving under-eye microneedle patch. The needles are 0.3 mm cones made of hyaluronic acid that melt into the skin, and there is no serum vial and no stamp. Worth noting that its own FAQ describes microneedle technology as cleared for drug delivery and cosmetic use, which is a statement about a category of technology rather than a clearance held by that product.
• Novalift also sells dissolving under-eye patches, marketed across at least five near-identical storefronts we found under different domains. Again: no stamp, no serum vial.
• LUX Skin sells a 29 dollar product called a Micro Infusion Kit, and its own listing describes the part that touches your skin as a 0.3 mm micro-needle roller head, with the instruction to roll it over the face. A roller drags across the skin; a stamp presses straight down and lifts. That is a different mechanism, not a cheaper version of the same one. One head ships against four serum vials with no single-use statement and no sterilisation information anywhere, and its terms state that the company has no legal entity in the United States.
• Peptonix is the right device class in the wrong place. It is a 0.5 mm gold-plated single-use head on a 5 mL vial, which is exactly what the kits above are, but every product it sells is for the scalp and hair. There is no face version. If you found it searching for micro-infusion for your face, it is not that.
• Facile appears in these searches because a Pasadena skin clinic sells a treatment it calls microinfusion. It is a 650 dollar, twenty minute in-clinic appointment in which wrinkle relaxers and fillers are stamped into the skin by a practitioner. There is no at-home device to buy. It is not a competitor to anything in this table.
• Derm is not really a brand. The domain try-derm.com redirects to a company trading as THE DRM LAB, which does sell a 0.5 mm PDRN micro-infusion system with 24 needles and salmon-derived PDRN, and which is unusually direct in stating that its device is not FDA approved. As a search term, though, "derm" is overwhelmingly the front half of dermaroller, dermapen and dermastamp.

Worth separating two things people conflate: under-eye microneedle patches are a separate category from the micro-infusion stamps compared here, because the needles dissolve into the skin instead of delivering a separate serum, and we compare those brands in their own guide.

If what you actually want is a patch rather than a stamp, that is a reasonable thing to want, and it is a different purchase with a different technique. We keep a separate guide on how to use under-eye patches correctly, including the counterintuitive part about applying them to dry skin.

What we found when we checked the published depths

Depth is the specification buyers use to rank these kits, and it is the one the category discloses least consistently. When we read each brand's own published material in July 2026, the headline finding was that these systems are closer together than the marketing suggests. When that material was read, Seranova, Qure, Glov, Alqemi, Glamory and the MicroInfuser all published 0.5 mm somewhere on their own sites. Elixa and Rewind Glow publish no depth at all, and the Dr. Pen MIS20 kit was the single outlier at 0.25 mm. Two of those figures have since moved: as of 31 August 2026 Glov's main product page states 0.25 mm and Seranova's product page no longer states a depth.

The complication is that two of them publish more than one number. Seranova's own product pages state 0.5 mm, while an Amazon listing title for the same system states 0.05 mm, a tenfold difference that we think is a listing error rather than a second product. Glov stated 0.5 mm on two product pages and 0.25 mm on a third when read in July, and its main product page states 0.25 mm as of 31 August 2026. Qure is the most consistent of the three, stating 0.5 mm on both its product content and its safety guide.

We are flagging this rather than scoring it, because we cannot measure a competitor's needles and we will not build a ranking on a number a brand may have mistyped. If depth is your deciding factor, ask the brand directly and get the answer in writing.

Once you set depth aside, the difference between these nine kits is not how deep they go. It is what the serum touches on its way to the needles.

That is where they genuinely diverge, and it is verifiable from their own instructions. Seranova has the user open the device and fill it before attaching a head. Qure has the user pour an ampoule into the device chamber and fill it halfway. Glov uses a chamber the user fills, with a device bottle the brand says can be used indefinitely. All three are pour-and-fill designs. Alqemi and Rewind Glow are open fill as well, and the Dr. Pen listing does not describe how its ampoules and heads connect. Three systems use a sealed path in which the serum travels from a pre-filled vial onto a single-use head with nothing poured: the MicroInfuser, Elixa and Glamory. We are not the only sealed system here and we should not be read as claiming otherwise. What separates the three is that the MicroInfuser ampoule clicks onto the head without a peel-and-stopper step, which is a smaller difference than the gap between sealed and open fill.

To be fair to every open-fill brand here: all of them specify single-use needle heads, which is the part that matters most for infection risk and the part the safety literature is clearest about. The reused component in a pour-and-fill design is the chamber, not the needles.

Where the evidence is strong, and where it is thin

The evidence for micro-infusion splits cleanly in two, and conflating the halves is how this category gets oversold. Needling itself has real trial support at clinic depths. The specific proposition of a shallow home stamp paired with a peptide serum does not, and no brand in this comparison can honestly claim otherwise.

On the strong side: a 2021 systematic review in the International Wound Journal examined nine randomised controlled trials and found microneedling effective for atrophic acne scars, whether used alone or alongside other treatments, with no serious adverse effects reported across the included studies. A 2022 meta-analysis in Aesthetic Plastic Surgery pooled twelve randomised trials covering 414 participants and found a statistically significant improvement in objective scar scores for microneedling without radiofrequency. A 2017 systematic review in the Journal of Plastic, Reconstructive and Aesthetic Surgery reached a similar direction of travel while being direct about the methodological weaknesses in the underlying trials.

On the thin side: PDRN. The mechanism is well described. PDRN binds the adenosine A2A receptor and engages nucleotide salvage pathways, which in laboratory and animal models supports fibroblast activity, angiogenesis and an anti-inflammatory response. But a 2026 narrative review in Cureus states the limitations plainly, listing a lack of randomised controlled trials in human aesthetic cohorts, small sample sizes, variability between formulations, and an absence of long-term follow-up. Most of the clinical PDRN literature also concerns injected or post-procedure use, not a cosmetic serum delivered through half-millimetre channels at home.

What the evidence does not show

Most pages in this category cite studies. Very few say what those studies fail to establish. Here is the honest boundary, and it constrains what we are willing to claim about our own kit as much as anyone else's.

There is one adverse-event finding that deserves more attention than it gets, because it is the strongest argument for using the serum a device was designed around. In a case series in JAMA Dermatology, three women developed facial granulomas after microneedling, and tissue cultures came back negative. The reaction was not to a contaminated needle. It was to the topical product itself being driven into the dermis, where a moisturiser was never meant to go. A later systematic review reaches the same practical conclusion, advising caution when microneedling is used together with products not approved for intradermal use.

This is also why the serum question is not a minor accessory decision. A micro-infusion device is a delivery mechanism, and it is indifferent to whether what you load into it belongs under your skin.

The PDRN sourcing question, answered honestly

PDRN is a mixture of DNA fragments, and the category norm is to extract it from fish. A 2022 review in the anti-aging literature describes PDRN as fragments mainly extracted from the sperm cells of salmon trout or chum salmon, which is where the popular name for the treatment comes from. Fermentation-derived PDRN is produced by controlled fermentation instead, so the PDRN molecule itself carries no fish-derived material.

EvenSkyn's Syntha-Pep serum uses fermentation-derived PDRN. We think that is a genuine point of difference and we say so. We also have to be equally clear about the other half of the label: the same serum contains marine-derived hydrolyzed collagen, used at low concentration as a humectant and film former. So the serum does contain material of marine origin, and it is not vegan, and anyone with a fish or shellfish allergy should not use it without speaking to their doctor first. A brand that tells you about the fermentation and stays quiet about the marine collagen is telling you half a story.

What a session costs in time and effort

Cost in this category is commonly reported as the sum of the device and its consumables, since every session consumes a head and an ampoule. Rather than quote figures that change, the useful arithmetic is per-session frequency: on a fortnightly schedule you use roughly twenty-six heads and twenty-six ampoules a year, and any kit sold with a subscription is priced against that number. Compare kits on the consumable cost per session, not the entry price of the handset.

Time cost is small. A full session on our device runs about five to ten minutes from assembly to the final pat-down, plus the evening afterwards with no makeup, no gym and no actives.

How to run a session correctly

Technique changes the result more than brand choice does, and most disappointing outcomes trace back to one of three errors: pressing too hard, sliding instead of stamping, or skipping the pause that lets serum reach the needles. The sequence below follows our own manual.

1. Patch test on a small, less visible area 24 hours before your first full session.
2. Pause retinoids, AHAs, BHAs and physical exfoliants for 48 hours beforehand.
3. Double cleanse, dry with a clean towel, then wash your hands and sanitise the work surface.
4. Break the ampoule seal, click on a fresh sterile head, then rest the device needles-down for one to two minutes so serum reaches the chamber.
5. Stamp with light taps, overlapping each stamp about halfway onto the previous one. Lift fully between stamps. Never drag.
6. Work the face in zones, staying outside the orbital bone entirely.
7. Pat the remaining serum into face and neck, then discard both the head and the ampoule. Heads are sharps and need a puncture-resistant container.
8. Skip makeup, sweat, hot showers and actives for the rest of the day. Use broad-spectrum SPF 30 or higher every morning for the next three days.

Who should not use one of these devices

Stop and speak to a clinician before buying if any of the following apply. This list is drawn from our own manual and applies broadly across the category.

• Oral isotretinoin now or within the past six months. This is an absolute contraindication.
• Prescribed anticoagulants or daily aspirin therapy, which raise bruising and bleeding risk even at shallow depths.
• Pregnancy or breastfeeding.
• A personal or family history of keloid or hypertrophic scarring.
• Active eczema, psoriasis or dermatitis in the treatment area, active cystic acne, cold sores, or any open or infected skin.
• A known fish or shellfish allergy, given the marine collagen in our serum.
• Recent chemical peel, laser treatment or sunburn, or skin that is still red, peeling or tender.

People with deeper skin tones should introduce treatment conservatively and watch for early pigment change, since post-inflammatory hyperpigmentation is the risk that shows up most often when a shallow device is used too aggressively.

Frequently asked questions

References

1. Sitohang IBS, Sirait SAP, Suryanegara J. Microneedling in the treatment of atrophic scars: a systematic review of randomised controlled trials. International Wound Journal. 2021. PMID 33538106. DOI 10.1111/iwj.13559.
2. Microneedling monotherapy for acne scar: systematic review and meta-analysis of randomized controlled trials. Aesthetic Plastic Surgery. 2022. DOI 10.1007/s00266-022-02845-3.
3. Hou A, Cohen B, Haimovic A, Elbuluk N. Microneedling: a comprehensive review. Dermatologic Surgery. 2017;43(3):321-339. PMID 27755171. DOI 10.1097/DSS.0000000000000924.
4. Microneedling: where do we stand now? A systematic review of the literature. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2017. ScienceDirect S1748681517302504.
5. United States Food and Drug Administration. Microneedling devices. Aesthetic and cosmetic devices guidance page. Cited for reuse and infection guidance only.
6. Recent advances in microneedling-assisted cosmetic applications. Cosmetics. 2024;11(2):51. DOI 10.3390/cosmetics11020051.
7. Polydeoxyribonucleotide (PDRN) in post-procedure recovery in aesthetic medicine: a narrative review. Cureus. 2026. PMID 42299173.
8. Polydeoxyribonucleotide in skincare and cosmetics: mechanisms, therapeutic applications and advancements beyond wound healing and anti-aging. Journal of Skin and Stem Cell. 2025; article 159728.
9. Polydeoxyribonucleotide: a promising skin anti-aging agent. Chinese Journal of Plastic and Reconstructive Surgery. 2022. ScienceDirect S2096691122000723.
10. EvenSkyn MicroInfuser User Manual, Edition 1 (2026). Manufacturer documentation, read 28 July 2026.
11. Sandby-Moller J, Poulsen T, Wulf HC. Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Dermato-Venereologica. 2003;83(6):410-413. PMID 14690333. DOI 10.1080/00015550310015419.
12. Aust MC, Fernandes D, Kolokythas P, Kaplan HM, Vogt PM. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles, and skin laxity. Plastic and Reconstructive Surgery. 2008;121(4):1421-1429. PMID 18349665. DOI 10.1097/01.prs.0000304612.72899.02.
13. Donnelly RF, Garland MJ, Morrow DI, Migalska K, Singh TR, Majithiya R, Woolfson AD. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. Journal of Controlled Release. 2010;147(3):333-341. PMID 20727929. DOI 10.1016/j.jconrel.2010.08.008.
14. Fong S, Mahmood E, Sanabria B, Ouellette S, Rao BK. In vivo reflectance confocal microscopy evaluation of microneedle patch penetration depth. Journal of Drugs in Dermatology. 2023;22(11):1107-1110. PMID 37943270. DOI 10.36849/JDD.6994.
15. Schmitt L, Marquardt Y, Amann P, Heise R, Huth L, Wagner-Schiffler S, Huth S, Baron JM. Comprehensive molecular characterization of microneedling therapy in a human three-dimensional skin model. PLOS ONE. 2018;13(9):e0204318. PMID 30235356. DOI 10.1371/journal.pone.0204318.
16. Alster TS, Graham PM. Microneedling: a review and practical guide. Dermatologic Surgery. 2018;44(3):397-404. PMID 28796657. DOI 10.1097/DSS.0000000000001248.
17. El-Domyati M, Moftah NH, Ahmed AM, Ibrahim MR. Evaluation of microneedling depth of penetration in management of atrophic acne scars: a split-face comparative study. International Journal of Dermatology. 2024;63(5):632-638. PMID 38159109. DOI 10.1111/ijd.17006.
18. Nalluri BN, Anusha SS, Bramhini SR, Amulya J, Sultana AS, Teja CU, Das DB. In vitro skin permeation enhancement of sumatriptan by microneedle application. Current Drug Delivery. 2015;12(6):761-769. PMID 25739035. DOI 10.2174/1567201812666150304123150.
19. Omolu A, Bailly M, Day RM. Assessment of solid microneedle rollers to enhance transmembrane delivery of doxycycline and inhibition of MMP activity. Drug Delivery. 2017;24(1):942-951. PMID 28618841. DOI 10.1080/10717544.2017.1337826.
20. Harris AG, Naidoo C, Murrell DF. Skin needling as a treatment for acne scarring: an up-to-date review of the literature. International Journal of Women's Dermatology. 2015;1(2):77-81. PMID 28491962. DOI 10.1016/j.ijwd.2015.03.004.
21. Chu S, Foulad DP, Atanaskova Mesinkovska N. Safety profile for microneedling: a systematic review. Dermatologic Surgery. 2021;47(9):1249-1254. PMID 34448760. DOI 10.1097/01.DSS.0000790428.70373.f6.
22. Lee CA, Baek JS, Kwag DG, Lee HJ, Park J, Cho CW. Enhancement of skin permeation of vitamin C using vibrating microneedles. Translational and Clinical Pharmacology. 2017;25(1):15-20. PMID 32095454. DOI 10.12793/tcp.2017.25.1.15.
23. Nagshabandi KN, Alojayri R, Alghufaili A, Alkallabi M. Microinfusion of medications into the skin as a drug delivery technique: a narrative review. Dermatology Reports. 2025. PMID 41186422. DOI 10.4081/dr.2025.10306.
24. Squadrito F, Bitto A, Irrera N, Pizzino G, Pallio G, Minutoli L, Altavilla D. Pharmacological activity and clinical use of PDRN. Frontiers in Pharmacology. 2017;8:224. PMID 28491036. DOI 10.3389/fphar.2017.00224.
25. Lampridou S, Bassett S, Cavallini M, Christopoulos G. The effectiveness of polynucleotides in esthetic medicine: a systematic review. Journal of Cosmetic Dermatology. 2025;24(2):e16721. PMID 39645667. DOI 10.1111/jocd.16721.
26. Yogya Y, Wanitphakdeedecha R, Wongdama S, Nanchaipruek Y, Yan C, Rakchart S. Efficacy and safety of using noninsulated microneedle radiofrequency alone versus in combination with polynucleotides for treatment of periorbital wrinkles. Dermatology and Therapy. 2022;12(5):1133-1145. PMID 35501660. DOI 10.1007/s13555-022-00729-7.
27. Stadelman-Behar AM, Gehre MN, Atallah L, Clarke T, Leonso AA, Jojola F, et al. Investigation of presumptive HIV transmission associated with receipt of platelet-rich plasma microneedling facials at a spa among former spa clients, New Mexico, 2018-2023. MMWR Morbidity and Mortality Weekly Report. 2024;73(16):372-376. DOI 10.15585/mmwr.mm7316a3.
28. Soltani-Arabshahi R, Wong JW, Duffy KL, Powell DL. Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation. JAMA Dermatology. 2014;150(1):68-72. PMID 24258303. DOI 10.1001/jamadermatol.2013.6955.
29. Gowda A, Healey B, Ezaldein H, Merati M. A systematic review examining the potential adverse effects of microneedling. Journal of Clinical and Aesthetic Dermatology. 2021;14(1):45-54. PMID 33584968.
30. Quinlan DJ, Ghanem AM, Hassan H. Topical growth factors and home-based microneedling for facial skin rejuvenation. Journal of Cosmetic Dermatology. 2022;21(8):3469-3478. PMID 34951101. DOI 10.1111/jocd.14650.
31. Manufacturer documentation for Elixa, Alqemi and Glamory, read from each brand's own site on 11 August 2026.

Keep reading

• At-home micro-infusion: the complete guide
• Is at-home micro-infusion safe?
• Salmon PDRN or bioengineered PDRN
• How often should you do at-home micro-infusion?
• Micro-infusion before and after: what is realistic in 12 weeks